CompoAtlas

Kidz / Les Zamis Constipation

Natural health product licensed in Canada

Licence holder
Distripharm Inc.
NPN or DIN-HM
80021002
Status
Active licence
Licence date
29 July 2010
Revision date
Not provided
Form
Gouttes
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Bryonia alba

Source : Racine

6 CHNot calculated
Lycopodium clavatum

Source : Spores séchées

6 CHNot calculated
Causticum

Source : Causticum d'Hahnemann

6 CHNot calculated

Non-medicinal ingredients

Eau purifiée, Benzoate de sodium, Cyclamate de sodium, Glycérine, Sorbitol, Sorbate de potassium, Acid citrique

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 1 year ; maximum: 5 yearsminimum: 5 Goutte(s) ; maximum: 10 Goutte(s)minimum: 1 day ; maximum: 3 days
Enfantsminimum: 6 years ; maximum: 11 yearsminimum: 5 Goutte(s) ; maximum: 15 Goutte(s)minimum: 1 day ; maximum: 3 days
Nourrissonsmaximum: 11 monthsminimum: 1 Goutte(s) ; maximum: 5 Goutte(s)minimum: 1 day ; maximum: 3 days

Uses authorised in Canada

Un médicament homéopathique pour traiter les troubles liés à la constipation : Constipation de selles déshydratées, selles petites et insuffisantes, expulsion douloureuse et prolongée. Abdomen tendu et douloureux.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80021002

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line